4.7 Article

Selective Processing of Social Stimuli in the Superficial Amygdala

期刊

HUMAN BRAIN MAPPING
卷 30, 期 10, 页码 3332-3338

出版社

WILEY
DOI: 10.1002/hbm.20755

关键词

amygdala; emotional; face; fMRI; social; superficial amygdala; probabilistic map

资金

  1. German Federal Ministry of Education
  2. Research (BMBF) [01GW0671]
  3. German Research Foundation (DFG) [HU1302/2-1]

向作者/读者索取更多资源

The human amygdala plays a pivotal role in the processing of socially significant information. Anatomical studies show that the human amygdala is not a single homogeneous structure but is composed of segregable subregions. These have recently been functionally delineated by using a combination of functional magnetic resonance imaging (WRI) and cytoarchitectonically defined probabilistic maps. However, the response characteristics and individual contribution of these subregions to the processing of social-emotional stimuli are little understood. Here, we used this novel technique to segregate intra-amygdalar responses to facial expressions and nonsocial control stimuli. We localized facial expression-evoked signal changes bilaterally in the superficial amygdala, which suggests that this subregion selectively extracts the social value of incoming sensory information. Hum Brain Mapp 30:3332-3338, 2009. (C) 2009 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Clinical Neurology

The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools

Melanie Filser, Axel Buchner, Gereon Rudolf Fink, Stefan M. Gold, Iris-Katharina Penner

Summary: Patients with multiple sclerosis (MS) are at increased risk of experiencing mental health problems, including depression and anxiety. However, there is limited knowledge about the assessment and association of these affective symptoms in MS. Further research is needed to improve diagnosis and care.

JOURNAL OF NEUROLOGY (2023)

Article Oncology

Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET

Michael M. Wollring, Jan-Michael Werner, Elena K. Bauer, Caroline Tscherpel, Garry S. Ceccon, Philipp Lohmann, Gabriele Stoffels, Christoph Kabbasch, Roland Goldbrunner, Gereon R. Fink, Karl-Josef Langen, Norbert Galldiks

Summary: This study evaluated the use of FET PET and MRI for early response assessment in recurrent glioma patients treated with lomustine-based chemotherapy. The results suggest that FET PET provides complementary information to RANO criteria for response evaluation early after treatment initiation.

NEURO-ONCOLOGY (2023)

Review Oncology

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas

Michael M. Wollring, Jan-Michael Werner, Garry Ceccon, Philipp Lohmann, Christian P. Filss, Gereon R. Fink, Karl-Josef Langen, Norbert Galldiks

Summary: PET imaging using radiolabeled amino acids combined with MRI is a valuable diagnostic tool in managing brain tumor patients. This review provides an overview of PET studies in glioma patients with IDH mutation, which typically do not show contrast enhancement on MRI. The review focuses on the role of amino acid PET in differential diagnosis, treatment planning, and response assessment in patients with IDH-mutant gliomas.

JOURNAL OF NEURO-ONCOLOGY (2023)

Article Clinical Neurology

Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort

Ann-Katrin Schild, Yasemin Goereci, Daniel Scharfenberg, Kim Klein, Joachim Luelling, Dix Meiberth, Finja Schweitzer, Sophie Stuermer, Philip Zeyen, Derya Sahin, Gereon R. Fink, Frank Jessen, Christiana Franke, Oezguer A. Onur, Josef Kessler, Clemens Warnke, Franziska Maier

Summary: The aim of this study was to assess the neuropsychological profile of patients with asymptomatic to mild/moderate acute COVID-19 disease. The study found that approximately 60% of participants reported cognitive deficits, particularly in the domains of learning/memory and executive functions. These deficits were associated with daytime sleepiness but not with depression, anxiety, sleep quality, general health status, or fatigue.

JOURNAL OF NEUROLOGY (2023)

Article Neurosciences

Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool

Anja Schaffrath, Sophia Schleyken, Aline Seger, Hannah Jergas, Pelin Ozduzenciler, Marlene Pils, Lara Bloemeke, Anneliese Cousin, Johannes Willbold, Tuyen Bujnicki, Oliver Bannach, Gereon R. Fink, Dieter Willbold, Michael Sommerauer, Michael T. Barbe, Gultekin Tamguney

Summary: This study used surface-based fluorescence intensity distribution analysis (sFIDA) to detect and quantify single particles of alpha-synuclein aggregates in stool samples of 94 PD patients, 72 isolated rapid eye movement sleep behavior disorder (iRBD) patients, and 51 healthy controls. The results showed significantly elevated concentrations of alpha-synuclein aggregates in stool samples of iRBD patients compared to controls (p = 0.024) or PD patients (p < 0.001). The study suggests that measuring alpha-synuclein aggregates in stool using the sFIDA assay could support the diagnosis of prodromal synucleinopathies.

NPJ PARKINSONS DISEASE (2023)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Differentiation of a Falcine Meningioma From Cerebral Venous Sinus Thrombosis Using DOTATATE PET

Isabelle Stetter, Jan-Michael Werner, Michael Schroeter, Claudia Baumann, Janina Neuneier, Marc Schlamann, Matthias Schmidt, Alexander Drzezga, Gereon R. Fink, Norbert Galldiks

Summary: Differentiating brain tumors from nonneoplastic lesions using conventional MRI may be challenging. Clinical symptoms often remain unspecific, and imaging findings from MRI may be inconclusive. PET with the radiolabeled somatostatin receptor ligand DOTATATE was performed, and it facilitated the diagnosis of a falcine meningioma consistent with its value for the differential diagnosis of meningioma.

CLINICAL NUCLEAR MEDICINE (2023)

Article Clinical Neurology

Visuo-spatial processing is linked to cortical glutamate dynamics in Parkinson's disease - a 7-T functional magnetic resonance spectroscopy study

Anja Ophey, Ezequiel Farrher, Nora Pagel, Aline Seger, Christopher E. J. Doppler, N. Jon Shah, Elke Kalbe, Gereon R. Fink, Michael Sommerauer

Summary: Cognitive decline is a common and debilitating symptom in patients with Parkinson's disease. Metabolic changes in the occipital cortex during visual processing may serve as a biomarker for cognitive decline in these patients.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Oncology

The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis

Alexander Heinzel, Felix M. Mottaghy, Christian Filss, Gabriele Stoffels, Philipp Lohmann, Michel Friedrich, Nadim J. Shah, Svenja Caspers, Carolin Weiss Lucas, Maximilian I. Ruge, Norbert Galldiks, Gereon R. Fink, Karl-Josef Langen, Martin Kocher

Summary: This study investigated the impact of tumor development and multimodality therapy on health-related quality of life (HRQoL) in glioma patients. The results showed that right hemisphere gliomas were associated with less favorable outcomes in most functional domains except communication ability. This relationship was mainly observed in T2/FLAIR lesions involving structural and functional networks in the right hemisphere.

JOURNAL OF NEURO-ONCOLOGY (2023)

Article Immunology

Kinesin-5 inhibition improves neural regeneration in experimental autoimmune neuritis

Felix Kohle, Robin Ackfeld, Franziska Hommen, Ines Klein, Martin K. R. Svacina, Christian Schneider, Gereon R. R. Fink, Mohammed Barham, David Vilchez, Helmar C. C. Lehmann

Summary: This study evaluated the neuro-regenerative effects of the small molecule kinesin-5 inhibitor monastrol in a rodent model of acute autoimmune neuropathies. The results showed that treatment with monastrol improved the functional and histological recovery of neuropathies and promoted the regeneration of nerve terminals, possibly through accelerated motor neurite outgrowth.

JOURNAL OF NEUROINFLAMMATION (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Amino Acid PET in Neurooncology

Norbert Galldiks, Philipp Lohmann, Gereon R. Fink, Karl-Josef Langen

Summary: For decades, amino acid PET tracers have been used to optimize diagnostics in brain tumor patients, with clinical indications including differentiation of neoplasm from nonneoplastic etiologies, delineation of tumor extent for further diagnostic and treatment planning, differentiation of treatment-related changes, and assessment of response to anticancer therapy. This article focuses on the diagnostic value of amino acid PET for patients with glioblastoma or metastatic brain cancer.

JOURNAL OF NUCLEAR MEDICINE (2023)

Article Clinical Neurology

Status epilepticus and benzodiazepine treatment: Use, underdosing and outcome-insights from a retrospective, multicentre registry

Felix Kohle, Marie Madlener, Emanuel F. Bruno, Gereon R. Fink, Volker Limmroth, Lothar Burghaus, Michael P. Malter

Summary: This study revealed that most patients with status epilepticus (SE) were not effectively treated with benzodiazepines (BZDs) according to current guidelines. Sufficient dosing of BZDs was found to be beneficial for patients with generalised convulsive SE, but not for other types of SE. Treatment decisions guided by the semiology of SE are crucial, and further evidence is urgently needed for the management of non-generalised convulsive SE.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2023)

Article Clinical Neurology

Subjective and Objective Cognitive Deficits in Patients with Post-COVID Syndrome A Challenge for Neuropsychologists

Ann-Katrin Schild, Daniel Scharfenberg, Lukas Kirchner, Kim Klein, Anton Regorius, Yasemin Goereci, Dix Meiberth, Lena Sannemann, Joachim Luelling, Finja Schweitzer, Gereon R. Fink, Frank Jessen, Christiana Franke, Oezguer Onur, Stefanie Jost, Clemens Warnke, Franziska Maier

Summary: Cognitive impairment is a common symptom of post-COVID syndrome (PCS), but there is inconsistency between subjective cognitive complaints (SCC) and objective results. This study investigated this discrepancy and found a 40% difference between subjective reports and test results. Patients with SCC and objective impairment showed elevated fatigue and reduced quality of life. The study suggests that more patients will likely request neuropsychological assessments even after mild infections.

ZEITSCHRIFT FUR NEUROPSYCHOLOGIE (2023)

Article Clinical Neurology

Seizures at stroke onset: A case-control study

Ji-Won Kim, Henning R. Stetefeld, Gereon R. Fink, Michael P. Malter

Summary: This study reports on the clinical practice in managing stroke patients with seizures at onset (SaO) from a large tertiary stroke center in Germany. The data show that SaO is rare in stroke patients but associated with more extensive strokes and increased in-hospital mortality.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2023)

Article Chemistry, Analytical

Accelerometric Classification of Resting and Postural Tremor Amplitude

Christina van der Linden, Thea Berger, Gregor A. Brandt, Joshua N. Strelow, Hannah Jergas, Juan Carlos Baldermann, Veerle Visser-Vandewalle, Gereon R. Fink, Michael T. Barbe, Jan Niklas Petry-Schmelzer, Till A. Dembek

Summary: Clinical rating scales for tremor have limitations, and reliable quantitative approaches are needed. This study investigated the use of accelerometry metrics to objectively classify tremor amplitude and compared them to clinical ratings. The results showed that accelerometry can reliably quantify tremor amplitude, with finger-worn accelerometry performing slightly better.

SENSORS (2023)

Article Clinical Neurology

Transcranial Direct Current Stimulation Reverses Stroke-Induced Network Alterations in Mice

Stefan J. J. Blaschke, Susan Vlachakis, Niklas Pallast, Helene L. L. Walter, Lukas J. J. Volz, Dirk Wiedermann, Gereon R. R. Fink, Mathias Hoehn, Markus Aswendt, Michael Schroeter, Maria A. A. Rueger

Summary: In this study, the researchers investigated whether transcranial direct current stimulation (tDCS) can alter the network changes caused by cerebral ischemia and whether functional network parameters can predict the therapeutic efficacy of tDCS. The results showed that tDCS reversed the increased connectivity and reduced characteristic path length caused by ischemia. Additionally, early network changes and the network configuration prior to stroke predicted motor recovery.

STROKE (2023)

暂无数据